Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Table 8. Immunohistochemical Differential Chart for Primary Malignant Epithelial Tumors of the Ovary

Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Differential Diagnosis of Small Round Blue Cell Tumors

Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Table 3. Breast Cancer Genotyping Based on Immunohistochemical Antibodies

Note:1. Based on DNA microarray analysis: Breast cancer is classified into the four subtypes mentioned above. The Her-2 overexpression ...
Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Immunohistochemical Differentiation of Carcinoma, Mesothelioma, and Reactive Mesothelial Cells

Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Immunodiagnostic Approach for Adult Renal Epithelial Cell Tumors

Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Prognostic Indicators for Colorectal Cancer

Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Prognosis-Related Proteins in Breast Cancer and Their Expression Significance

Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Expression of High Molecular Weight Keratin in Normal Tissues and Tumors

Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Table 1. Expression and Role of Myoepithelial Cell Markers in Breast Tumors: Benign Breast Epithelial Tumors vs. Carcinoma in Situ vs. Invasive Carcinoma

Note:1. Benign glandular ducts or ductal carcinoma in situ are often surrounded by myoepithelial cells (except for microglandular adeno...
Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Positive Expression Rates of CDX2 and Villin at Moderate Intensity or Above in Adenocarcinoma

Continue reading
  • ‹
  • 1
  • 2
  • 3
  • 4
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar